A bright idea? : the promise and peril of a memory drug

Thesis (S.M. in Science Writing)--Massachusetts Institute of Technology, Dept. of Humanities, Graduate Program in Science Writing, 2007. === Includes bibliographical references (leaves 49-51). === In the MIT lab of neuropharmacologist Richard Wurtman, rodents that received a new Alzheimer's dru...

Full description

Bibliographic Details
Main Author: Dowd, William (William Michael)
Other Authors: Robert Kanigel.
Format: Others
Language:English
Published: Massachusetts Institute of Technology 2008
Subjects:
Online Access:http://hdl.handle.net/1721.1/42146
id ndltd-MIT-oai-dspace.mit.edu-1721.1-42146
record_format oai_dc
spelling ndltd-MIT-oai-dspace.mit.edu-1721.1-421462019-05-02T15:32:17Z A bright idea? : the promise and peril of a memory drug Promise and peril of a memory drug Dowd, William (William Michael) Robert Kanigel. Massachusetts Institute of Technology. Graduate Program in Science Writing. Massachusetts Institute of Technology. Graduate Program in Science Writing. Graduate Program in Science Writing. Thesis (S.M. in Science Writing)--Massachusetts Institute of Technology, Dept. of Humanities, Graduate Program in Science Writing, 2007. Includes bibliographical references (leaves 49-51). In the MIT lab of neuropharmacologist Richard Wurtman, rodents that received a new Alzheimer's drug have shown a marked improvement in learning and memory. They are able to master elaborate mazes in half the time of their all-natural counterparts. Wurtman theorizes that the memory loss and dementia associated with Alzheimer's disease is caused not by amyloid plaques and tangles but by a gradual deterioration of the brain's synapses. Wurtman's drug-a cocktail of three dietary supplements including uridine, choline, and an omega-3 fatty acid called DHA-is designed to generate more synapses. The three ingredients deliver the stimulus and raw material needed to create more phosphatidylcholine, a major component of neuronal membrane. More membrane, the thinking goes, means more neuronal encounters, more synapses, and more relayed messages. Wurtman's cocktail has just entered a massive clinical trial involving 10,000 Alzheimer's patients spread across 10 European countries. The same drug that could preserve brain function in Alzheimer's patients also has potential as a memory drug for healthy people. This thesis explores the ethical questions surrounding such biotechnological enhancement. What might be the benefits and drawbacks of taking a memory booster? Could a class-like division eventually arise between those who get the drug and those who do not? Could the molecular manipulations of a smart drug-what some call "cosmetic pharmacology"--change qualities that are inextricable from who we are? by William Dowd. S.M.in Science Writing 2008-09-03T14:43:25Z 2008-09-03T14:43:25Z 2007 2007 Thesis http://hdl.handle.net/1721.1/42146 228414126 eng M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission. http://dspace.mit.edu/handle/1721.1/7582 51 leaves application/pdf Massachusetts Institute of Technology
collection NDLTD
language English
format Others
sources NDLTD
topic Graduate Program in Science Writing.
spellingShingle Graduate Program in Science Writing.
Dowd, William (William Michael)
A bright idea? : the promise and peril of a memory drug
description Thesis (S.M. in Science Writing)--Massachusetts Institute of Technology, Dept. of Humanities, Graduate Program in Science Writing, 2007. === Includes bibliographical references (leaves 49-51). === In the MIT lab of neuropharmacologist Richard Wurtman, rodents that received a new Alzheimer's drug have shown a marked improvement in learning and memory. They are able to master elaborate mazes in half the time of their all-natural counterparts. Wurtman theorizes that the memory loss and dementia associated with Alzheimer's disease is caused not by amyloid plaques and tangles but by a gradual deterioration of the brain's synapses. Wurtman's drug-a cocktail of three dietary supplements including uridine, choline, and an omega-3 fatty acid called DHA-is designed to generate more synapses. The three ingredients deliver the stimulus and raw material needed to create more phosphatidylcholine, a major component of neuronal membrane. More membrane, the thinking goes, means more neuronal encounters, more synapses, and more relayed messages. Wurtman's cocktail has just entered a massive clinical trial involving 10,000 Alzheimer's patients spread across 10 European countries. The same drug that could preserve brain function in Alzheimer's patients also has potential as a memory drug for healthy people. This thesis explores the ethical questions surrounding such biotechnological enhancement. What might be the benefits and drawbacks of taking a memory booster? Could a class-like division eventually arise between those who get the drug and those who do not? Could the molecular manipulations of a smart drug-what some call "cosmetic pharmacology"--change qualities that are inextricable from who we are? === by William Dowd. === S.M.in Science Writing
author2 Robert Kanigel.
author_facet Robert Kanigel.
Dowd, William (William Michael)
author Dowd, William (William Michael)
author_sort Dowd, William (William Michael)
title A bright idea? : the promise and peril of a memory drug
title_short A bright idea? : the promise and peril of a memory drug
title_full A bright idea? : the promise and peril of a memory drug
title_fullStr A bright idea? : the promise and peril of a memory drug
title_full_unstemmed A bright idea? : the promise and peril of a memory drug
title_sort bright idea? : the promise and peril of a memory drug
publisher Massachusetts Institute of Technology
publishDate 2008
url http://hdl.handle.net/1721.1/42146
work_keys_str_mv AT dowdwilliamwilliammichael abrightideathepromiseandperilofamemorydrug
AT dowdwilliamwilliammichael promiseandperilofamemorydrug
AT dowdwilliamwilliammichael brightideathepromiseandperilofamemorydrug
_version_ 1719023716296294400